Xencor to Present at the 2021 RBC Capital Markets Global Healthcare Virtual Conference Read more about Xencor to Present at the 2021 RBC Capital Markets Global Healthcare Virtual Conference
Xencor Reports First Quarter 2021 Financial Results Read more about Xencor Reports First Quarter 2021 Financial Results
Xencor Doses First Subject in Phase 1 Study of XmAb®564, an Engineered IL-2 Cytokine in Development for Autoimmune Diseases Read more about Xencor Doses First Subject in Phase 1 Study of XmAb®564, an Engineered IL-2 Cytokine in Development for Autoimmune Diseases
Xencor to Host First Quarter 2021 Financial Results Webcast and Conference Call on May 5, 2021 Read more about Xencor to Host First Quarter 2021 Financial Results Webcast and Conference Call on May 5, 2021
Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021 Read more about Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021
Xencor to Present Preclinical Data from Four Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2021 Read more about Xencor to Present Preclinical Data from Four Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2021
Xencor to Present at the Barclays Global Healthcare Conference Read more about Xencor to Present at the Barclays Global Healthcare Conference
Xencor and UCLA Enter Collaboration to Discover and Develop Novel XmAb® Therapeutics Read more about Xencor and UCLA Enter Collaboration to Discover and Develop Novel XmAb® Therapeutics
Xencor Reports Fourth Quarter and Full Year 2020 Financial Results Read more about Xencor Reports Fourth Quarter and Full Year 2020 Financial Results
Xencor to Host Fourth Quarter and Full Year 2020 Financial Results Webcast and Conference Call on February 23, 2021 Read more about Xencor to Host Fourth Quarter and Full Year 2020 Financial Results Webcast and Conference Call on February 23, 2021
